Energy stocks get a broad boost from rising crude oil prices
Shares of oil and gas companies traded broadly higher Monday, as crude oil prices climbed toward a fourth-straight gain. The Energy Select Sector SPDR exchange-traded fund (XLE) rallied 0.8% in premarket trading, with 21 of its 23 equity components trading higher. after rising 4.9% over a five-day win streak through Friday. Among the energy ETF's (XLE) more-active components, shares of Occidental Petroleum Corp. (OXY) advanced 0.9%, Devon Energy Corp. (DVN) tacked on 0.8%, Marathon Oil Corp. (MRO) rose 1.2%, Exxon Mobil Corp. (XOM) gained 0.6% and Chevron Corp. (CVX) tacked on 0.6%. Crude oil futures rose 1.1%, and have hiked up 5.5% in four days. The gain on Monday comes after Saudi Arabia said it would extend a 1 million barrel-a-day production cut through August, while Russia said it would cut exports this month by 500,000 barrels a day.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-03-23 0837ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track